The Future of Bioprocess Containers Market

Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry

(EMAILWIRE.COM, September 28, 2021 ) According to data published in the Generics and Biosimilars Initiative Journal, around twelve biological products with global sales of more than USD 67 billion will be exposed to biosimilar competition by 2020.

The patent expiry of blockbuster drugs has resulted in increased R&D spending by pharmaceutical and biotechnology companies. Patent expiry of biologics leads to increasing R&D of biologics and shifts biologics from the pipeline to commercial production. As the development and manufacturing costs of biologics are very high, companies are now gradually focusing on techniques that are more economical than traditional biomanufacturing methods.

On the basis of type, the bioprocess containers market is segmented into 2D bioprocess containers, 3D bioprocess containers, and other containers and accessories. In 2020, the 2D bioprocess containers segment accounted for the largest share of the bioprocess containers market. 2D bioprocess containers are frequently used in cell harvesting and for the transportation of bulk drug products and bulk drug precursors.

The demand for biopharmaceuticals among the senior population is increasing as the elderly are more prone to various diseases/disorders that can be treated using biologics. This has resulted in the increasing focus of biopharmaceutical companies developing affordable biologics at lower costs. As bioprocess containers have wide applications in research & process development, the adoption of BPCs is increasing with the growth in the development and manufacturing of biologics and biosimilars.

For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832

The Asia Pacific region is the fastest-growing region of the bioprocess containers market in 2020.

In 2020, the Asia Pacific region accounted for the fasted growing region of the bioprocess containers market. Factors such as the growing biopharmaceuticals industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies and key players in the region, and the growing number of CROs & CMOs in several APAC countries are contributing to the growth of this market.

Some of the leading players operating in the bioprocess containers market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany).